24th Annual Advanced Vitreoretinal Techniques And Technology Symposium

We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal.

At Janssen, we never stop working toward a future where disease is a thing of the past.

We're a leading global eye health organization that is solely focused on helping you see better to live better.

At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system.

Iveric Bio is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs.

Get in the Ideas Business. At Regeneron we believe that when the right idea finds the right team, powerful change is possible.

REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy.

EyePoint Pharmaceuticals (Nasdaq: EYPT) is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company's pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery

Coherus BioSciences is the leading biologics platform company solely focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medicines in regulated markets worldwide. Founded in 2010, Coherus is a late-stage biologics platform company focused on th

Through RCA’s physician-centered practice management model, physicians continue to drive clinical care and practice culture, while benefitting from the business expertise, resources, and shared best practices. RCA seeks to expand our mission by partnering with leading retina specialists who are pas

To provide customer care for the target group of vitreoretinal surgeons in North and South America, OCULUS Optikgeräte GmbH, Germany founded OCULUS Surgical, Inc. in Florida, USA in the fall of 2012. At company headquarters in Wetzlar, a new department was created too – the Surgical Division. In 201

Norlase is an emerging global ophthalmic medical device company developing next-generation laser solutions for the treatment of retina and glaucoma disease. Norlase is comprised of worldwide industry leaders and experts in ophthalmology, laser technology, medical device development and customer care

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company focused on transforming disease management by keeping people first—the patients who benefit from the information that our advanced diagnostic tests provide, the clinicians who use our tests to guide disease management decisions, our

As a leader in eye care for over 70 years, Allergan, an AbbVie company, has discovered, developed, and delivered innovative therapeutic products. We have launched over 125 eye care products and invested billions of dollars in new treatments for the most prevalent eye conditions including glaucoma,

Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer.

For more than 35 years D.O.R.C. has worked intensively with leading top surgeons. Therefore at D.O.R.C. we know exactly which requirements instruments and equipment must satisfy. Our knowledge, combined with a unique mix of talent for the development of new ideas, high design quality and a strong pr

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 coun